Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures

Investment thesis

The Leibniz Institute DSMZ exists to preserve, characterise, and distribute authenticated bioresources (microorganisms, cell lines, viruses) while generating reference data through genomics and bioinformatics. It functions as national research infrastructure for the Leibniz Association, enabling reproducible science and compliant access to genetic resources.

• Strategic agenda: bioresource security and traceability — DSMZ maintains >75,000 accessions (bacteria, archaea, fungi, cell lines, viruses) and provides authenticated strains for academia and industry [1].
• Strategic agenda: genomics-led identification — The institute runs TYGS (Type (Strain) Genome Server) and supports BacDive, enabling genome-based classification of prokaryotes without overestimating phylogenetic confidence [2].
• Strategic agenda: compliance with international access-and-benefit-sharing — DSMZ is the first registered collection in the EU for the Nagoya Protocol, ensuring legal transfer of genetic resources [1].
• Strategic agenda: health and bioeconomy relevance — Dedicated departments cover microbial ecology, genomics, plant viruses, and bioresources for bioeconomy and health research [2].

Credibility: the institute’s own website lists its research fields, collection sizes, and online tools; Wikipedia confirms its Leibniz membership, Budapest Treaty recognition, and Nagoya Protocol registration [2][1].

Value add

Beyond supplying authenticated bioresources, the DSMZ provides traceability, compliance, and reference data that reduce regulatory and reproducibility risk.

• Networks — Membership in the Leibniz Association and the German Center for Infection Research connects users to a broader research ecosystem [1].
• Facilities — State-of-the-art diagnostic methods for plant viruses and mycoplasma detection support quality control [2].
• Credibility — Budapest Treaty recognition (since 1981) and Nagoya Protocol registration (since 2018) signal international legal standing [1].
• Follow-on eligibility — Depositing strains can establish a company as a source for future collaborations or licensing [2].

Fit verdict: The DSMZ is a supplier and infrastructure partner, not a funder. It is a fit for biotech or agri-tech startups that need authenticated strains, cell lines, or compliance documentation, but not for capital-seeking founders.

Founder diligence script:

• Does my startup need authenticated microbial strains or cell lines for R&D or production?
• Do I require STR profiling or mycoplasma detection for regulatory compliance?
• Can I afford service fees or deposit agreements, or do I need non-dilutive capital?
• Am I prepared to comply with Nagoya Protocol requirements for genetic resource access?

Portfolio focus

The DSMZ’s “portfolio” consists of its preserved bioresources and published reference data, which cluster around microbial diversity, human cell lines, and plant viruses.

• Microbial diversity — Over 41,500 bacterial strains, 800 archaeal strains, and 10,600 fungal/yeast strains form the core collection [2].
• Human & animal cell lines — Nearly 1,000 authenticated cell lines are maintained, with STR profiling available for verification [2].
• Plant viruses — Over 1,000 plant viruses are stored, supporting safe exchange of genetic resources between regions [2].
• Bioinformatic outputs — BacDive, TYGS, and LPSN are continuously updated with genome and nomenclature data from deposited strains [2].

Interconnection: the portfolio is the collection itself; a founder’s “fit” is measured by whether their strain or cell line aligns with these domains.